Oppenheimer Biotechnology Austin, TX - 78728

Oppenheimer Biotechnology is categorized under Biological Products Manufacturers in Austin, TX and active since 1991.

Oppenheimer Biotechnology was established in 1991, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Biological Products Manufacturers business, which does work in the B2B market, and is classified as a Biological Products Manufacturers, under code number 3254140 by the NAICS.

If you are seeking more information, feel free to contact Jen Neve, President at the company’s single location by writing to 13803 Quitman Pass, Austin, Texas TX 78728 or by phoning (512) 474-1016. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Oppenheimer Biotechnology
Contact Person: Jen Neve, President
Address: 13803 Quitman Pass, Austin, Texas 78728
Phone Number: (512) 474-1016
Website Address: obio.com
Annual Revenue (USD): $5.000.000 to $9.999.999
Founded: 1991
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Biological Products Manufacturers
SIC Code: 2836
NAICS Code: 3254140
Share This Business:

Oppenheimer Biotechnology was started in 1991 to provide professional Biological Products Manufacturers under the SIC code 2836 and NAICS code 3254140. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.

Feel free to contact Jen Neve, President for inquiries that concern Oppenheimer Biotechnology by calling the company number (512) 474-1016, as your correspondence is most welcome. Additionally, the physical location of the single location of Oppenheimer Biotechnology can be found at the coordinates 30.43128,-97.68169 as well as the street address 13803 Quitman Pass in Austin, Texas 78728.

For its online presence, you may visit Oppenheimer Biotechnology’s website at obio.com and engage with its social media outlets through on Twitter and on Facebook.